Canakinumab in a subgroup of patients with COVID-19.

ABSTRACT:

SUBMITTER: Ucciferri C 

PROVIDER: S-EPMC7272172 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature